Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
Highlights ► Systematic review of global hepatitis B prevalence and modeling of data. ► HBsAg-positive persons increased from 223 million in 1990 to 240 million in 2005. ► HBsAg prevalence varied geographically with highest endemicity in sub-Saharan Africa. ► HBsAg prevalence decreased overall but g...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2012-03, Vol.30 (12), p.2212-2219 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2219 |
|---|---|
| container_issue | 12 |
| container_start_page | 2212 |
| container_title | Vaccine |
| container_volume | 30 |
| creator | Ott, J.J Stevens, G.A Groeger, J Wiersma, S.T |
| description | Highlights ► Systematic review of global hepatitis B prevalence and modeling of data. ► HBsAg-positive persons increased from 223 million in 1990 to 240 million in 2005. ► HBsAg prevalence varied geographically with highest endemicity in sub-Saharan Africa. ► HBsAg prevalence decreased overall but global differences exist. ► Demographic changes call for targeted hepatitis B prevention. |
| doi_str_mv | 10.1016/j.vaccine.2011.12.116 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_968172335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X11020779</els_id><sourcerecordid>968172335</sourcerecordid><originalsourceid>FETCH-LOGICAL-c592t-12b47506dfe9dcfd26f9b90fad612db7a5f47bb473077ca59c79adfa80bd8a683</originalsourceid><addsrcrecordid>eNqFkkFv1DAQhS0EokvhJ4AsceCU4HE2TswB1FbQIlVwACRulmOPFy_ZONjJov33ONoFpF568uWb9zzvDSHPgZXAQLzelnttjB-w5AygBF4CiAdkBW1TFbyG9iFZMS7WxRrY9zPyJKUtY6yuQD4mZ5zzphKCr8h83YdO9xRHb3HnQx82Bxoc_YGjnvzkE72kex_nRP3g0Ew-DG_oJ_xNMU1-pydMC603WKQRjXfe0JvLdLGhCWMYI-51j4NBqgdLcVgsjJ8OT8kjp_uEz07vOfn24f3Xq5vi9vP1x6uL28LUkk8F8G7d1ExYh9IaZ7lwspPMaSuA267RtVs3XWYq1jRG19I0UlunW9bZVou2OievjrpjDL_m_GW188lg3-sBw5yUFC00vKrq-0leySW8hXx5h9yGOQ55DQX1ugHRMrk410fKxJBSRKfGmPOKBwVMLQWqrToVqJYCFXCVC8xzL07qc7dD-2_qb2MZeHcEMOe29xhVMn6J2PqY-1E2-Hst3t5RML0fvNH9Tzxg-r-NSlwx9WW5ouWIABjPOcvqD-8SxNM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547168098</pqid></control><display><type>article</type><title>Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ott, J.J ; Stevens, G.A ; Groeger, J ; Wiersma, S.T</creator><creatorcontrib>Ott, J.J ; Stevens, G.A ; Groeger, J ; Wiersma, S.T</creatorcontrib><description>Highlights ► Systematic review of global hepatitis B prevalence and modeling of data. ► HBsAg-positive persons increased from 223 million in 1990 to 240 million in 2005. ► HBsAg prevalence varied geographically with highest endemicity in sub-Saharan Africa. ► HBsAg prevalence decreased overall but global differences exist. ► Demographic changes call for targeted hepatitis B prevention.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2011.12.116</identifier><identifier>PMID: 22273662</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age ; Age distribution ; Age Factors ; Aged ; Aged, 80 and over ; Allergy and Immunology ; Antigens ; Bayesian analysis ; Cancer ; Child ; Child, Preschool ; Children ; Chronic infection ; Cirrhosis ; Data processing ; Disease ; Epidemiology ; Estimates ; Fatalities ; Female ; Geography ; Global Health ; Hepatitis ; Hepatitis B ; Hepatitis B surface antigen ; Hepatitis B surface antigen (HBsAg) ; Hepatitis B Surface Antigens - blood ; Hepatitis B virus ; Hepatitis B, Chronic - epidemiology ; Humans ; Immunization ; Infant ; Infant, Newborn ; Infection ; Infections ; Literature reviews ; Liver cancer ; Low income groups ; Male ; Mathematical models ; Middle Aged ; Modeling ; Morbidity ; Mortality ; Population ; Prevalence ; Reporting requirements ; Reviews ; Risk factors ; Seroepidemiologic Studies ; Sex Factors ; Studies ; Systematic review ; Vaccines ; Young Adult</subject><ispartof>Vaccine, 2012-03, Vol.30 (12), p.2212-2219</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Mar 9, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c592t-12b47506dfe9dcfd26f9b90fad612db7a5f47bb473077ca59c79adfa80bd8a683</citedby><cites>FETCH-LOGICAL-c592t-12b47506dfe9dcfd26f9b90fad612db7a5f47bb473077ca59c79adfa80bd8a683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X11020779$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22273662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ott, J.J</creatorcontrib><creatorcontrib>Stevens, G.A</creatorcontrib><creatorcontrib>Groeger, J</creatorcontrib><creatorcontrib>Wiersma, S.T</creatorcontrib><title>Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights ► Systematic review of global hepatitis B prevalence and modeling of data. ► HBsAg-positive persons increased from 223 million in 1990 to 240 million in 2005. ► HBsAg prevalence varied geographically with highest endemicity in sub-Saharan Africa. ► HBsAg prevalence decreased overall but global differences exist. ► Demographic changes call for targeted hepatitis B prevention.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Age distribution</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Allergy and Immunology</subject><subject>Antigens</subject><subject>Bayesian analysis</subject><subject>Cancer</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Chronic infection</subject><subject>Cirrhosis</subject><subject>Data processing</subject><subject>Disease</subject><subject>Epidemiology</subject><subject>Estimates</subject><subject>Fatalities</subject><subject>Female</subject><subject>Geography</subject><subject>Global Health</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis B surface antigen</subject><subject>Hepatitis B surface antigen (HBsAg)</subject><subject>Hepatitis B Surface Antigens - blood</subject><subject>Hepatitis B virus</subject><subject>Hepatitis B, Chronic - epidemiology</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infection</subject><subject>Infections</subject><subject>Literature reviews</subject><subject>Liver cancer</subject><subject>Low income groups</subject><subject>Male</subject><subject>Mathematical models</subject><subject>Middle Aged</subject><subject>Modeling</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Population</subject><subject>Prevalence</subject><subject>Reporting requirements</subject><subject>Reviews</subject><subject>Risk factors</subject><subject>Seroepidemiologic Studies</subject><subject>Sex Factors</subject><subject>Studies</subject><subject>Systematic review</subject><subject>Vaccines</subject><subject>Young Adult</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkkFv1DAQhS0EokvhJ4AsceCU4HE2TswB1FbQIlVwACRulmOPFy_ZONjJov33ONoFpF568uWb9zzvDSHPgZXAQLzelnttjB-w5AygBF4CiAdkBW1TFbyG9iFZMS7WxRrY9zPyJKUtY6yuQD4mZ5zzphKCr8h83YdO9xRHb3HnQx82Bxoc_YGjnvzkE72kex_nRP3g0Ew-DG_oJ_xNMU1-pydMC603WKQRjXfe0JvLdLGhCWMYI-51j4NBqgdLcVgsjJ8OT8kjp_uEz07vOfn24f3Xq5vi9vP1x6uL28LUkk8F8G7d1ExYh9IaZ7lwspPMaSuA267RtVs3XWYq1jRG19I0UlunW9bZVou2OievjrpjDL_m_GW188lg3-sBw5yUFC00vKrq-0leySW8hXx5h9yGOQ55DQX1ugHRMrk410fKxJBSRKfGmPOKBwVMLQWqrToVqJYCFXCVC8xzL07qc7dD-2_qb2MZeHcEMOe29xhVMn6J2PqY-1E2-Hst3t5RML0fvNH9Tzxg-r-NSlwx9WW5ouWIABjPOcvqD-8SxNM</recordid><startdate>20120309</startdate><enddate>20120309</enddate><creator>Ott, J.J</creator><creator>Stevens, G.A</creator><creator>Groeger, J</creator><creator>Wiersma, S.T</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7U1</scope><scope>7U2</scope></search><sort><creationdate>20120309</creationdate><title>Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity</title><author>Ott, J.J ; Stevens, G.A ; Groeger, J ; Wiersma, S.T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c592t-12b47506dfe9dcfd26f9b90fad612db7a5f47bb473077ca59c79adfa80bd8a683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Age distribution</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Allergy and Immunology</topic><topic>Antigens</topic><topic>Bayesian analysis</topic><topic>Cancer</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Chronic infection</topic><topic>Cirrhosis</topic><topic>Data processing</topic><topic>Disease</topic><topic>Epidemiology</topic><topic>Estimates</topic><topic>Fatalities</topic><topic>Female</topic><topic>Geography</topic><topic>Global Health</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis B surface antigen</topic><topic>Hepatitis B surface antigen (HBsAg)</topic><topic>Hepatitis B Surface Antigens - blood</topic><topic>Hepatitis B virus</topic><topic>Hepatitis B, Chronic - epidemiology</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infection</topic><topic>Infections</topic><topic>Literature reviews</topic><topic>Liver cancer</topic><topic>Low income groups</topic><topic>Male</topic><topic>Mathematical models</topic><topic>Middle Aged</topic><topic>Modeling</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Population</topic><topic>Prevalence</topic><topic>Reporting requirements</topic><topic>Reviews</topic><topic>Risk factors</topic><topic>Seroepidemiologic Studies</topic><topic>Sex Factors</topic><topic>Studies</topic><topic>Systematic review</topic><topic>Vaccines</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ott, J.J</creatorcontrib><creatorcontrib>Stevens, G.A</creatorcontrib><creatorcontrib>Groeger, J</creatorcontrib><creatorcontrib>Wiersma, S.T</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ott, J.J</au><au>Stevens, G.A</au><au>Groeger, J</au><au>Wiersma, S.T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2012-03-09</date><risdate>2012</risdate><volume>30</volume><issue>12</issue><spage>2212</spage><epage>2219</epage><pages>2212-2219</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights ► Systematic review of global hepatitis B prevalence and modeling of data. ► HBsAg-positive persons increased from 223 million in 1990 to 240 million in 2005. ► HBsAg prevalence varied geographically with highest endemicity in sub-Saharan Africa. ► HBsAg prevalence decreased overall but global differences exist. ► Demographic changes call for targeted hepatitis B prevention.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>22273662</pmid><doi>10.1016/j.vaccine.2011.12.116</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2012-03, Vol.30 (12), p.2212-2219 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_968172335 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Age Age distribution Age Factors Aged Aged, 80 and over Allergy and Immunology Antigens Bayesian analysis Cancer Child Child, Preschool Children Chronic infection Cirrhosis Data processing Disease Epidemiology Estimates Fatalities Female Geography Global Health Hepatitis Hepatitis B Hepatitis B surface antigen Hepatitis B surface antigen (HBsAg) Hepatitis B Surface Antigens - blood Hepatitis B virus Hepatitis B, Chronic - epidemiology Humans Immunization Infant Infant, Newborn Infection Infections Literature reviews Liver cancer Low income groups Male Mathematical models Middle Aged Modeling Morbidity Mortality Population Prevalence Reporting requirements Reviews Risk factors Seroepidemiologic Studies Sex Factors Studies Systematic review Vaccines Young Adult |
| title | Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T17%3A18%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Global%20epidemiology%20of%20hepatitis%20B%20virus%20infection:%20New%20estimates%20of%20age-specific%20HBsAg%20seroprevalence%20and%20endemicity&rft.jtitle=Vaccine&rft.au=Ott,%20J.J&rft.date=2012-03-09&rft.volume=30&rft.issue=12&rft.spage=2212&rft.epage=2219&rft.pages=2212-2219&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2011.12.116&rft_dat=%3Cproquest_cross%3E968172335%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547168098&rft_id=info:pmid/22273662&rft_els_id=1_s2_0_S0264410X11020779&rfr_iscdi=true |